November 18, 2026
Health news, explained with evidence
LIVE

Study Links Specific Metabolic Profiles in Inflammatory Bowel Disease to Higher Cardiovascular and Mortality Risks

❤️ Conditions & Care 2 min read 👁 5

A new observational UK Biobank study led by researchers at institutions including West China Hospital and Wuhan University suggests that distinct metabolic profiles marked by higher GlycA levels are linked to increased risks of cardiovascular disease and mortality in patients with inflammatory bowel disease.

❤️Conditions & Care

Key points

  • Observational study analyzed UK Biobank data to evaluate metabolic profiles in IBD patients.
  • A profile with higher GlycA levels (IC) was linked to increased risks of composite cardiovascular disease, heart failure, and death.
  • Authors stress the findings are exploratory, do not establish causality, and require further external validation.

A recent observational study published in Nature Health Sciences has examined how specific metabolic profiles relate to long-term cardiovascular disease and mortality in individuals with inflammatory bowel disease (IBD). Researchers analyzed UK Biobank proton nuclear magnetic resonance data to identify exploratory metabolic patterns, sorting participants into distinct groups based on features like GlycA and lipid measures. The analysis revealed a specific profile labeled IC, characterized by higher GlycA levels along with some lower lipid measures, which researchers evaluated against non-IBD control groups.

According to the findings, this IC metabolic profile was linked to higher risks of composite cardiovascular disease in both ulcerative colitis and Crohn's disease patients. Furthermore, the pattern showed statistical associations with elevated risks of heart failure and overall mortality in both conditions. The investigators adjusted their outcome models for polygenic risk scores to refine the comparisons against individuals without IBD.

However, the study authors emphasize that these single-cohort observational findings are strictly hypothesis-generating and do not establish a causal relationship, clinical utility, or external validity. The investigation relied on exploratory data modeling, where cluster separation was modest and method-dependent, feature-selection stability was limited, and incremental discrimination changes remained small. Because the research is observational and at an early stage, it cannot prove that the metabolic markers directly cause heart conditions or mortality.

What to know: Patients with inflammatory bowel disease should be aware that systemic metabolic factors may influence long-term cardiovascular health, though this study is preliminary. Readers should always talk to a qualified medical doctor for personal health decisions, diagnostic guidance, or medical advice.

Source Nature Health Sciences — nature.com/articles/s41598-026-78473-7 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.